Lyme disease has been on the rise in the United States over the past 30 years, which underscores the need for faster, more ...

Ancient DNA analysis has unveiled a previously unknown group of people who resided near the land bridge connecting Asia and ...

Twist Bioscience now appears more reasonably priced, which should lead to solid returns as fundamentals recover in H2 FY26.

In summary, repeated head impacts may trigger inflammation in the brain, which can promote the accumulation of DNA mutations ...

About 400 years ago, a cross between cabernet franc and sauvignon blanc gave birth to cabernet sauvignon. Today, cabernet ...

The Pinal County Medical Examiner's Office, in collaboration with Othram, has identified skeletal remains found over a year ...

Scientists examine the mummified remains of a 39,000-year-old mammoth nicknamed Yuka, whose tissue yielded ancient RNA in a ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

The global forensic genomics market size was valued at US$ 0.5 Bn in 2024 and is projected to reach US$ 2.4 Bn by 2035, ...

Every human face is different, but scientists still know surprisingly little about how our DNA shapes these differences. To ...

Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...

Twist Bioscience Corporation (NASDAQ:TWST) is one of the best gene-editing stocks to buy according to hedge funds.